首页|德谷胰岛素联合二甲双胍缓释片治疗2型糖尿病患者的效果分析

德谷胰岛素联合二甲双胍缓释片治疗2型糖尿病患者的效果分析

Analysis of the Effectiveness of Insulin Degludec Combined with Metfor-min Extended-release Tablets in the Treatment of Patients with Type 2 Diabetes Mellitus

扫码查看
目的 分析在2型糖尿病患者治疗中二甲双胍缓释片、德谷胰岛素联合使用的疗效.方法 随机选取2022年1月—2023年4月甘肃省天水市第四人民医院内分泌科收治的84例2型糖尿病患者为研究对象,采用随机数表法分为参照组(42例)与研究组(42例),参照组采用甘精胰岛素联合二甲双胍缓释片治疗方案,研究组采用德谷胰岛素联合二甲双胍缓释片治疗方案.比较两组治疗前后胰岛素功能指标、血糖指标,统计两组不良反应发生率.结果 治疗后,研究组3项血糖指标水平低于参照组,差异有统计学意义(P均<0.05).治疗后,研究组胰岛素抵抗指数、空腹胰岛素低于参照组,胰岛β细胞功能指数高于参照组,差异有统计学意义(P均<0.05).两组皮疹、唇舌肿胀、低血糖、腹泻不良反应总发生率比较,差异无统计学意义(P>0.05).结论 在二甲双胍缓释片治疗基础上采用德谷胰岛素可提高疗效,改善患者胰岛细胞功能,显著降低血糖水平,不会额外增加不良反应.
Objective To analyze the efficacy of the combination of metformin extended-release tablets and insulin degludec in the treatment of type 2 diabetes mellitus patients.Methods Eighty-four patients who were treated for type 2 diabetes mellitus in the Endocrinology Department of Tianshui Fourth People's Hospital of,Gansu Province from January 2022 to April 2023 were randomly selected as the study objects and divided into the reference group(42 pa-tients)and the study group(42 patients)using the random number table method,and the control group was treated with the treatment regimen of glargine insulin combined with metformin extended-release tablets and the study group was treated with insulin degludec combined with metformin extended-release tablets.The insulin function indexes and blood glucose indexes before and after treatment,and count the incidence of adverse reactions in the two groups were compared.Results After treatment,the levels of the three blood glucose indexes in the study group were lower than those in the reference group,and the differences were statistically significant(all P<0.05).After treatment,the ho-meostatic model assessment of insulin resistance index and fasting insulin of the study group were lower than that of the reference group,and the homeostatic model assessment of islet β-cell function index was higher than that of the reference group,and the differences were statistically significant(all P<0.05).Compared with the total incidence of rash,lip and tongue swelling,hypoglycemia and diarrhea in both groups,the difference was not statistically significant(P>0.05).Conclusion The use of insulin degludec on the basis of metformin extended-release tablets treatment can enhance the efficacy,improve the function of patients'pancreatic islet cells,and significantly reduce the blood glu-cose level without additional adverse reactions.

Type 2 diabetes mellitusInsulin degludecMetformin extended-release tablets

何凤、王小龙

展开 >

甘肃省天水市第四人民医院内分泌科,甘肃天水 741020

甘肃省天水市张家川县龙山镇中心卫生院骨科,甘肃张家川 741500

2型糖尿病 德谷胰岛素 二甲双胍缓释片

2024

糖尿病新世界
中国病理生理学会

糖尿病新世界

影响因子:0.461
ISSN:1672-4062
年,卷(期):2024.27(7)
  • 11